GSK Investigational Site
Porąbka 43-353
0 studies enrolling now · 4 studies all time
What they study most
Diabetes Mellitus, Type 2, Influenza
Studies at this site
- Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™ — Completed
- Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older — Completed
- Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM) — Completed
- Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive — Completed